HomeInsightsStock Comparison

Anupam Rasayan India Ltd vs Archit Organosys Ltd Stock Comparison

Anupam Rasayan India Ltd vs Archit Organosys Ltd Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

  • The Latest Trading Price of Anupam Rasayan India Ltd is ₹ 1239 as of 18 Mar 14:54 . The P/E Ratio of Anupam Rasayan India Ltd changed from 51.3 on March 2023 to 89.8 on March 2025 . This represents a CAGR of 11.85% over 5 yearsThe P/E Ratio of Archit Organosys Ltd changed from 10.9 on March 2023 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Anupam Rasayan India Ltd changed from ₹ 9287 crore on March 2023 to ₹ 8382 crore on March 2025 . This represents a CAGR of -2.03% over 5 yearsThe Market Cap of Archit Organosys Ltd changed from ₹ 123.92 crore on March 2023 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Anupam Rasayan India Ltd for the Dec '25 is ₹ 514.55 crore as compare to the Sep '25 revenue of ₹ 739.19 crore. This represent the decline of -30.39% The revenue of Archit Organosys Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Anupam Rasayan India Ltd for the Dec '25 is ₹ 129.58 crore as compare to the Sep '25 ebitda of ₹ 143.58 crore. This represent the decline of -9.75% The ebitda of Archit Organosys Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Anupam Rasayan India Ltd changed from ₹ 12.21 crore to ₹ 60.59 crore over 7 quarters. This represents a CAGR of 149.77% The net profit of Archit Organosys Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Anupam Rasayan India Ltd changed from 7.15 % on March 2021 to 11.35 % on March 2025 . This represents a CAGR of 9.68% over 5 yearsThe Dividend Payout of Archit Organosys Ltd changed from 14.99 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Anupam Rasayan India Ltd

  • Anupam Rasayan India Limited was initially formed as a Partnership Firm as 'Anupam Rasayan' effective from April 01, 1984 at Surat in Gujarat.
  • The Partnership Firm was registered under the Indian Partnership Act, 1932 with Registrar of Firms, Surat in October 22, 1984. Subsequently, the Partnership Firm converted into a joint stock company and was registered as a Public Limited Company under the name 'Anupam Rasayan India Limited' dated September 30, 2003, issued by Registrar of Companies, Gujarat, Dadra and Nagar Haveli.
  • The Company received Certificate of Commencement of Business, issued by Assistant Registrar of Companies, Gujarat, on November 20, 2003. The Company is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.

About Archit Organosys Ltd

  • Archit Organosys Limited was originally incorporated on 04th August 1993 as 'Shri Chlochem Limited'.
  • The Company got the name changed to Archit Organosys Limited from Shri Chlochem Limited effective from 19th May, 2012.
  • The Company is mainly engaged in the business of manufacturing and trading of various chemical products. Major customers of the Company include several large Indian and International companies who are engaged in the Agrochemical Manufacturing Sector, Pharmaceuticals Manufacturing Sector and Cosmetics Manufacturing Sector.
  • Company has developed various product like MCA, SMCA, CAC and TCAC. Company is selling their products across Pan India as well as USA, Europe, Latin America, Other Asian Countries and South Africa.
  • These products are used mainly in pharmaceutical Intermediates like Ibuprofen, Diclofenac, Aceclofenac, Oil field chemicals used for Oil Drilling mainly In CMC manufacturing, Agriculture field product majorly 2,4 D-Acid and many others, surfactants and cosmetic products as well as day to day personal use products, also used in Pigment.

FAQs for the comparison of Anupam Rasayan India Ltd and Archit Organosys Ltd

Which company has a larger market capitalization, Anupam Rasayan India Ltd or Archit Organosys Ltd?

Market cap of Anupam Rasayan India Ltd is 14,069 Cr while Market cap of Archit Organosys Ltd is 75 Cr

What are the key factors driving the stock performance of Anupam Rasayan India Ltd and Archit Organosys Ltd?

The stock performance of Anupam Rasayan India Ltd and Archit Organosys Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anupam Rasayan India Ltd and Archit Organosys Ltd?

As of March 18, 2026, the Anupam Rasayan India Ltd stock price is INR ₹1235.85. On the other hand, Archit Organosys Ltd stock price is INR ₹36.57.

How do dividend payouts of Anupam Rasayan India Ltd and Archit Organosys Ltd compare?

To compare the dividend payouts of Anupam Rasayan India Ltd and Archit Organosys Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions